Country Trust Bank’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-101
Closed -$2K 353
2022
Q3
$2K Hold
101
﹤0.01% 345
2022
Q2
$2K Hold
101
﹤0.01% 346
2022
Q1
$4K Hold
101
﹤0.01% 362
2021
Q4
$6K Hold
101
﹤0.01% 381
2021
Q3
$9K Hold
101
﹤0.01% 340
2021
Q2
$11K Hold
101
﹤0.01% 300
2021
Q1
$11K Hold
101
﹤0.01% 285
2020
Q4
$11K Hold
101
﹤0.01% 276
2020
Q3
$14K Hold
101
﹤0.01% 234
2020
Q2
$33K Hold
101
﹤0.01% 173
2020
Q1
$9K Buy
+101
New +$6.23K ﹤0.01% 221

Other funds holding INO

Country Trust Bank's INO Position: Q4 2022 in Review

Country Trust Bank sold out of Inovio Pharmaceuticals (INO) in Q4 2022, closing a stake of 101 shares — an estimated $2K sold.

Country Trust Bank first reported a position in INO in Q1 2020 and held it in 11 quarters. The position peaked at $33K in Q2 2020. 183 funds tracked by Wall St. Rank hold INO as of Q4 2022.

  • Country Trust Bank reported no remaining Inovio Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Country Trust Bank sold 101 Inovio Pharmaceuticals shares in Q4 2022, an estimated $2K.
  • Country Trust Bank first reported a position in Inovio Pharmaceuticals in Q1 2020 and held it in 11 quarters.
  • Country Trust Bank's Inovio Pharmaceuticals position peaked at $33K in Q2 2020.
  • 183 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2022.

Based on Country Trust Bank's 13F filing for Q4 2022, filed 18 Jan 2023.